Portal de Periódicos da CAPES

Sunitinib‐induced hand–foot syndrome in a renal cell carcinoma: A sclerodermatous and rheumatoid arthritis‐like case

2012; Wiley; Volume: 39; Issue: 11 Linguagem: Inglês

10.1111/j.1346-8138.2011.01486.x

1346-8138

Tsutomu Ohtsuka,

Chemotherapy-related skin toxicity

The Journal of DermatologyVolume 39, Issue 11 p. 943-944 LETTERS TO THE EDITOR Sunitinib-induced hand–foot syndrome in a renal cell carcinoma: A sclerodermatous and rheumatoid arthritis-like case Tsutomu OHTSUKA, Tsutomu OHTSUKA Department of Dermatology, International University of Health and Welfare Hospital, Nasushiobara, JapanSearch for more papers by this author Tsutomu OHTSUKA, Tsutomu OHTSUKA Department of Dermatology, International University of Health and Welfare Hospital, Nasushiobara, JapanSearch for more papers by this author First published: 19 January 2012 https://doi.org/10.1111/j.1346-8138.2011.01486.xCitations: 3 Tsutomu Ohtsuka, M.D., Ph.D., Department of Dermatology, International University of Health and Welfare Hospital, 537-3 Iguchi Nasushiobara, Tochigi 329-2763, Japan. Email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Chu D, Lacouture ME, Weiner E, Wu S. Risk of hand-foot skin reaction with the multitargeted kinase inhibitor sunitinib in patients with renal cell and non-renal cell carcinoma: a meta-analysis. Clin Genitourin Cancer 2009; 7: 11–19. 2 Fife DJ, Wu JJ, Behnam SE, Linden KG. Sunitinib-induced hand-foot syndrome: a new, distinct form. Clin Exp Dermatol 2010; 35: 200–201. 3 Sahai S, Swick BL. Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib. Int J Dermatol 2010; 49: 1203–1206. 4 Trindade F, Haro R, Fariña MC, Requena L. Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine. Am J Dermatopathol 2008; 30: 172–173. 5 van Erp NP, Eechoute K, van der Veldt AA et al. Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity. J Clin Oncol 2009; 27: 4406–4412. Citing Literature Volume39, Issue11November 2012Pages 943-944 ReferencesRelatedInformation